z-logo
open-access-imgOpen Access
A novel aromatase inhibitor, vorozole, shows antitumor activity and a decrease of tissue insulin-like growth factor-I level in 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Author(s) -
Noritaka Sugamata,
Yukio Koibuchi,
Y Iino,
Y Morishita
Publication year - 1999
Publication title -
international journal of oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.405
H-Index - 122
ISSN - 1019-6439
DOI - 10.3892/ijo.14.2.259
Subject(s) - dmba , 7,12 dimethylbenz[a]anthracene , medicine , endocrinology , aromatase inhibitor , mammary tumor , biology , oncogene , growth factor , insulin like growth factor , aromatase , cancer , breast cancer , cell cycle , receptor , carcinogenesis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom